About TFBS
 

当社について

設施介紹

Facility Facility
  • Xizhi cGMP Facility

    Xizhi cGMP Facility
    • New Taipei City, Taiwan
    • Established in 2019
    • 7,800 sq. ft.
    • R&D, Pre-Clinical & Pilot-Scale
    • Cell and Virus Banking
    • Viral Vector Manufacturing Line
    • AAV, Lentivirus, Retrovirus and Adenovirus
  • Zhubei cGMP Facility

    Zhubei cGMP Facility
    • Hsinchu County, Taiwan
    • To be completed in 2023
    • 53,000 sq. ft.
    • Late-Stage Clinical & Commercial-Scale
    • Cell and Virus Banking
    • Manufacturing Multi-suites up to 500L
    • Aseptic fill & finish
  • Microbiology QC Lab

    Microbiology QC Lab
    • CRO service
    • GLP/GMP
    • BSL-2
    • E.coli bank characterization
    • Plasmid release testing
    • Sterility/Mycoplasma/Endotoxin
  • Bioanalytical Lab

    Bioanalytical Lab
    • CRO service
    • GLP/GMP
    • BSL-2
    • Bank characterization
    • Biosafety testing
    • Biologics release testing
    • Clinical sample analysis
  • Animal Facility

    Bioanalytical Lab
    • CRO service
    • GLP
    • ABSL-2
    • Biosafety testing
    • Toxicity
    • Biodistribution
    • Immunogenicity
    • Tumorgenicity